Cel-Sci
CVM
#9791
Rank
C$66.39 M
Marketcap
C$7.90
Share price
-1.19%
Change (1 day)
-54.15%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : C$12.77 Million

According to Cel-Sci 's latest financial reports the company's total debt is C$12.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30C$13.06 M-16.89%
2024-09-30C$15.72 M-14.77%
2023-09-30C$18.44 M-12.52%
2022-09-30C$21.08 M4.08%
2021-09-30C$20.25 M9.25%
2020-09-30C$18.54 M3.67%
2019-09-30C$17.88 M4.11%
2018-09-30C$17.18 M-2.51%
2017-09-30C$17.62 M2.9%
2016-09-30C$17.12 M-7.39%
2015-09-30C$18.49 M1371.47%
2014-09-30C$1.25 M7.43%
2013-09-30C$1.16 M7.66%
2012-09-30C$1.08 M-79.03%
2011-09-30C$5.18 M355.28%
2010-09-30C$1.13 M-5.22%
2009-09-30C$1.2 M464.71%
2008-09-30C$0.21 M
2005-09-30C$0 M-7.09%
2004-09-30C$0 M-99.68%
2003-09-30C$1.17 M-58.05%
2002-09-30C$2.8 M5580.3%
2001-09-30C$0.04 M31.98%
2000-09-30C$0.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$62.34 B 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$74.30 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$94.29 M 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$2.67 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.24 B 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
C$0.87 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.90 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$0.75 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA